Table 1 Patient demographics and DSC imaging parameters.

From: The Impact of MRI Features and Observer Confidence on the Treatment Decision-Making for Patients with Untreated Glioma

Institution

Vendor and field strength

Imaging parameters

Histology

#patients

WHO grade

Age

Gender

KPS

[#patients]

[number of patients]

[DSC-MRI]

[median]

[range]

[female/male]

%

A [94]

Siemens 1.5T Avanto [42],

Sonata [6],

Symphony [46]

Axial 12–14 slices; single-shot GE EPI; 50–80 volumes; TR = 1400–1590 ms; TE = 30–52 ms; voxel size 1.8 × 1.8 × 5 mm3; slice spacing 1.5 mm; FA = 90°; 0.2 mmol/kg Gd-DTPA (Gadovist, Bayer Pharma AG)

DA

17

II

41

23–63

7/10

90–100

OA

6

II

40

26–70

3/3

100

OD

5

II

36

30–64

4/1

90–100

GA

3

II

52

41–69

1/2

100

AA

7

III

68

35–79

5/2

80–100

AOA

5

III

62

28–82

2/3

90–100

AOD

2

III

40

28–53

0/2

100

GBM

49

IV

60

40–78

23/26

50–100

B [126]

Siemens 1.5T Avanto [3];

Siemens 3T TimTrio [16];

GE 1.5T Signa HDxt [107]

Axial 14–16 slices; single-shot GE/SE EPI; 80 volumes; TR = 1400–1500 ms; TE = 20–40/100 ms; voxel size 1.9 × 1.9 × 5 mm3; slice spacing 1 mm; FA = 60°; 0.1–0.2 mmol/kg Gd-DTPA (Magnevist, Bayer Pharma AG)

DA

8

II

39

24–62

5/3

90–100

OA

8

II

39

26–55

3/5

90–100

OD

1

II

45

45

0/1

90

EP

1

II

68

68

0/1

100

CG

1

II

53

53

1/0

80

AA

24

III

49

26–87

10/14

60–100

AOA

9

III

40

21 74

4/5

90–100

AOD

2

III

58

37–78

0/2

70–90

GBM

72

IV

64

33–87

34/38

50–100

  1. Note. WHO = World Health Organization, KPS = Karnofsky performance status, GE = gradient echo, SE = spin echo, EPI = echo planar imaging,
  2. TR = repetition time, TE = echo time, FA = flip angle, Gd-DTPA = gadopentetate-dimeglumine, DA = Diffuse Astrocytoma, OA = Oligoastrocytoma,
  3. OD = Oligodendroglioma, EP = Ependymoma, CG = Chordoid glioma, AA = Anaplastic Astrocytoma, AOA = Anaplastic Oligoastrocytoma,
  4. AOD = Anaplastic Oligodendroglioma, GBM = Glioblastoma Multiforme.